2015 Blogging Develop Pricing 
Tech.Co
FEBRUARY 19, 2021
Martin Rushe, the CEO and founder of Selz wrote a blog post announcing the deal. ” However, the platform shuttered in 2015, just five years after its launch. Selz currently offers three monthly pricing plans which allow you to create your own store using its platform, or attach Selz' smarts to an existing site.
Xconomy
OCTOBER 28, 2016
. —Two Vertex rivals touted early-stage data at the NACFC conference: Belgium-based Galapagos , which is developing its own triple combination regimen, and Netherlands-based ProQr Therapeutics (NASDAQ: PRQR ), which is advancing an RNA-based CF drug sprayed into the lungs. THIS WEEK IN DRUG PRICING…. billion last year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
OCTOBER 27, 2016
Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says. They also queried 15 VC firms.
Tech Zulu Event
APRIL 18, 2016
Despite the benefits of developing an app, there are valid reasons why retailers choose not to invest in one. Developing a mobile app can be extremely expensive and some retailers believe it is futile to spend that money if a mobile-optimized site is already in place. MYTH: Development costs are too high.
Xconomy
JULY 7, 2016
As of the end of 2015, Pernix reported a headcount of 274. Consequently, Pernix’s stock price has suffered. Last month, Pernix disclosed that it risked delisting from the Nasdaq because its stock price had fallen below $1. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals.
Xconomy
AUGUST 26, 2016
Left untreated, Heather and Jessica, who have a slower-developing form of the disease, might expect to continue to get weaker as time goes on. Twenty-one orphan drugs were approved in 2015, a record for the second straight year. “It’s just little things like that where it’s a gradual loss of strength,” Heather says.
Xconomy
OCTOBER 14, 2016
in July 2015. —Cancer drug developer Accelerated Pharma, based in Westport, CT, outlined terms for a $17 million IPO. The stock price was down 10 percent as of Thursday’s close. But sagging sales have sent Illumina far down from last year’s peak. Here’s more from CNBC. THIS WEEK IN SICKLE CELL…. million in an IPO.
Expert insights. Personalized for you.
136 
Let's personalize your content